ArQule raises $69.6M follow-on

Cancer and rare disease company ArQule Inc. (NASDAQ:ARQL) raised $69.6 million through the sale of 12.7 million shares at $5.50 in a follow-on underwritten by Leerink, Needham, Roth Capital, B. Riley FBR and JonesTrading. The figures include the sale of a 1.7 million share overallotment on July 13. ...